Another Good News for Breast Cancer Patients (with ER positive, HER2 negative)

Another Good News for Breast Cancer Patients (with ER positive, HER2 negative)

In advanced breast cancer, two criteria when deciding suitability for hormonal therapy are: Estrogen receptor (ER) positive and HER2 negative NOT in visceral crisis Visceral crisis is defined as severe organ dysfunction as assessed by signs and symptoms, laboratory studies and rapid progression of disease. Visceral crisis is not the mere presence of visceral metastases … Continue reading Another Good News for Breast Cancer Patients (with ER positive, HER2 negative)

Good News for Breast Cancer Patients (with HER2-positive)

Good News for Breast Cancer Patients (with HER2-positive)

The first paragraph summed it well - drastic price reduction would enable more breast cancer patients with HER2-positive to be treated with trastuzumab. Trastuzumab treatment is heavily subsidised for patients who fits certain criteria in government hospitals. For these patients, this news won't affect them. Who will it benefit then? Besides adhering to KKM drug … Continue reading Good News for Breast Cancer Patients (with HER2-positive)

Improving Cancer Survival, By Patients Themselves

Improving Cancer Survival, By Patients Themselves

In order to improve prognosis/ survival of cancer patients, irrespective of the type and stage of cancers, patients should: Avoid Losing Weight Malnutrition, which leads to weight loss can be caused by various factors such as dietary avoidance/ 'pantang', dietary misconception, side effects from cancer treatments (low appetite/ nausea/ vomiting/ mucositis/ esophagitis/ diarrhea) or even … Continue reading Improving Cancer Survival, By Patients Themselves

Advanced/ Stage 4 Lung Cancer: Approved Immunotherapy in 2nd Line Treatment (Part 2 of 2)

Advanced/ Stage 4 Lung Cancer: Approved Immunotherapy in 2nd Line Treatment (Part 2 of 2)

I will try to play the devil advocate and give a balanced opinion here in regards to second-line immunotherapy treatment for lung cancer. In my first part, I put forward what pharmaceutical representatives often present to oncologists; highlighting positive numbers, glossing over large percentage reduction in risk of death and not mentioning 'hidden' information. The … Continue reading Advanced/ Stage 4 Lung Cancer: Approved Immunotherapy in 2nd Line Treatment (Part 2 of 2)

A Case of High Risk Localised Prostate Cancer with Nodal Positivity (N+) – Part 2

A Case of High Risk Localised Prostate Cancer with Nodal Positivity (N+) – Part 2

For this second part that I took a few days to prepare, I will first explain about nodal positivity in prostate cancer and then will try to give a fair review for both oncological and surgical management of localised prostate cancer with nodal positivity. Significances of Nodal Positivity (N+) for Prostate Cancer Let's focus on … Continue reading A Case of High Risk Localised Prostate Cancer with Nodal Positivity (N+) – Part 2